Use of oral anticoagulants and risk of prostate cancer: a population-based case–control study in Montreal, Canada View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-09

AUTHORS

Audrey Blanc-Lapierre, Deborah Weiss, Marie-Élise Parent

ABSTRACT

PURPOSE: A few recent epidemiological observations suggest that anticoagulant medications may protect against prostate cancer development. Most studies have been small or subjected to methodological issues, including potential confounding. We provide here new evidence on this association in the context of a population-based case-control study of prostate cancer conducted in Montreal, Canada. METHODS: Cases were 1,588 men with incident prostate cancer, aged ≤75 years, diagnosed across French hospitals in the Montreal area between 2005 and 2009. Concurrently, 1,618 population controls from the same residential area and age distribution (±5 years) were randomly selected from the electoral list of French-speaking men. In-person interviews elicited information on socio-demographic, lifestyle and environmental factors, along with a detailed medical history. Unconditional logistic regression was used to assess the association between lifetime use of anticoagulants and prostate cancer risk. RESULTS: 102 subjects (2.6 % of cases and 3.7 % of controls) reported a history of oral anticoagulant therapy. After controlling for age, ancestry, education, family history of prostate cancer, prostate cancer screening frequency, diabetes, body mass index and statin use, ever use of oral anticoagulants showed a weak inverse, non-statistically significant association with prostate cancer (odds ratio 0.76, 95% confidence interval 0.50-1.16). Similar results were observed in analyses considering duration of use or indication for use, restricted to subjects recently screened or stratified by cancer aggressiveness. CONCLUSIONS: Our findings provide weak support for a protective effect of oral anticoagulant therapy against prostate cancer. Further confirmation is required, especially in light of potential bleeding complications associated with anticoagulants. More... »

PAGES

1159-1166

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10552-014-0417-z

DOI

http://dx.doi.org/10.1007/s10552-014-0417-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1000302615

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24946744


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anticoagulants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Body Mass Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ethnic Groups", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interviews as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Logistic Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Odds Ratio", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quebec", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institut National de la Recherche Scientifique", 
          "id": "https://www.grid.ac/institutes/grid.418084.1", 
          "name": [
            "Epidemiology and Biostatistics Unit, INRS-Institut Armand-Frappier, Universit\u00e9 du Qu\u00e9bec, 531 Boul. des Prairies, Building 12, H7V 1B7, Laval, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Blanc-Lapierre", 
        "givenName": "Audrey", 
        "id": "sg:person.01202354504.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202354504.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut National de la Recherche Scientifique", 
          "id": "https://www.grid.ac/institutes/grid.418084.1", 
          "name": [
            "Epidemiology and Biostatistics Unit, INRS-Institut Armand-Frappier, Universit\u00e9 du Qu\u00e9bec, 531 Boul. des Prairies, Building 12, H7V 1B7, Laval, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Weiss", 
        "givenName": "Deborah", 
        "id": "sg:person.01106133736.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106133736.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al", 
          "id": "https://www.grid.ac/institutes/grid.410559.c", 
          "name": [
            "Epidemiology and Biostatistics Unit, INRS-Institut Armand-Frappier, Universit\u00e9 du Qu\u00e9bec, 531 Boul. des Prairies, Building 12, H7V 1B7, Laval, QC, Canada", 
            "Department of Social and Preventive Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC, Canada", 
            "University of Montreal Hospital Research Centre, Montr\u00e9al, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Parent", 
        "givenName": "Marie-\u00c9lise", 
        "id": "sg:person.01260315672.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260315672.25"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1093/aje/kwr268", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000858088"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1538-7836.2008.03044.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001482733"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jclinepi.2012.04.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002232854"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1538-7836.2003.00293.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002539354"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(07)70046-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005839562"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200006293422604", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007215434"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pds.1943", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009876921"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pds.1943", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009876921"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/thoraxjnl-2012-202592", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017817423"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/thoraxjnl-2012-202592", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017817423"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.biopha.2003.11.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022119176"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/oemed-2012-101211", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025048974"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/oemed-2012-101211", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025048974"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.22892", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030280079"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.22.4584", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033231702"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2010-08-304758", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033876215"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(97)10018-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037335380"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0895-4356(97)00040-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045577952"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1538-7836.2008.02928.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049082481"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2741/1891", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070914174"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076606316", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077469842", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081728229", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-09", 
    "datePublishedReg": "2014-09-01", 
    "description": "PURPOSE: A few recent epidemiological observations suggest that anticoagulant medications may protect against prostate cancer development. Most studies have been small or subjected to methodological issues, including potential confounding. We provide here new evidence on this association in the context of a population-based case-control study of prostate cancer conducted in Montreal, Canada.\nMETHODS: Cases were 1,588 men with incident prostate cancer, aged \u226475\u00a0years, diagnosed across French hospitals in the Montreal area between 2005 and 2009. Concurrently, 1,618 population controls from the same residential area and age distribution (\u00b15\u00a0years) were randomly selected from the electoral list of French-speaking men. In-person interviews elicited information on socio-demographic, lifestyle and environmental factors, along with a detailed medical history. Unconditional logistic regression was used to assess the association between lifetime use of anticoagulants and prostate cancer risk.\nRESULTS: 102 subjects (2.6\u00a0% of cases and 3.7\u00a0% of controls) reported a history of oral anticoagulant therapy. After controlling for age, ancestry, education, family history of prostate cancer, prostate cancer screening frequency, diabetes, body mass index and statin use, ever use of oral anticoagulants showed a weak inverse, non-statistically significant association with prostate cancer (odds ratio 0.76, 95% confidence interval 0.50-1.16). Similar results were observed in analyses considering duration of use or indication for use, restricted to subjects recently screened or stratified by cancer aggressiveness.\nCONCLUSIONS: Our findings provide weak support for a protective effect of oral anticoagulant therapy against prostate cancer. Further confirmation is required, especially in light of potential bleeding complications associated with anticoagulants.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10552-014-0417-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100917", 
        "issn": [
          "0957-5243", 
          "1573-7225"
        ], 
        "name": "Cancer Causes & Control", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "25"
      }
    ], 
    "name": "Use of oral anticoagulants and risk of prostate cancer: a population-based case\u2013control study in Montreal, Canada", 
    "pagination": "1159-1166", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "01702535e5df8c5ed3c4c3c49108bc6fada21e0cbc90ab554cfa625cccfcefb1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24946744"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9100846"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10552-014-0417-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1000302615"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10552-014-0417-z", 
      "https://app.dimensions.ai/details/publication/pub.1000302615"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T17:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000479.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s10552-014-0417-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10552-014-0417-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10552-014-0417-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10552-014-0417-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10552-014-0417-z'


 

This table displays all metadata directly associated to this object as RDF triples.

209 TRIPLES      21 PREDICATES      65 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10552-014-0417-z schema:about N0304d1260c934a108f51c1c75163f17b
2 N0f833ce8b83540d2acd70b39a00e78bd
3 N11c13a4c4c02455fbb1821ed9feb57d5
4 N1c80dfab14c6406cbef6848273ed5bb4
5 N1fa2eb743ea249718c01964c04f00a81
6 N3426d016172c4070922a1a10418ace10
7 N3ef97a0f2e41443d97d81cb7d5cfcdbd
8 N50e892c5f9694af49a209f0645359663
9 N61329f7f3fc649f39eaa92676518dda2
10 N652cc32bfa3c43f0ab7c8947ab111ca6
11 N67545b034eef475d877b10d1c81bd1db
12 N6dd5c8631ea74827836e5cfc43771332
13 Nb9ddcf6a48594073953d5b74fc03a474
14 Ne1ff597e47d040a1bc8b9248c0d5f0da
15 Nf3a57c81b24142259874a914a4c95617
16 Nf509e1d24be94675b3a48d111f72a6fd
17 anzsrc-for:11
18 anzsrc-for:1117
19 schema:author N3115b1bd7ca0430ba5221581a52eae64
20 schema:citation https://app.dimensions.ai/details/publication/pub.1076606316
21 https://app.dimensions.ai/details/publication/pub.1077469842
22 https://app.dimensions.ai/details/publication/pub.1081728229
23 https://doi.org/10.1002/cncr.22892
24 https://doi.org/10.1002/pds.1943
25 https://doi.org/10.1016/j.biopha.2003.11.007
26 https://doi.org/10.1016/j.jclinepi.2012.04.009
27 https://doi.org/10.1016/s0140-6736(97)10018-6
28 https://doi.org/10.1016/s0895-4356(97)00040-1
29 https://doi.org/10.1016/s1470-2045(07)70046-3
30 https://doi.org/10.1046/j.1538-7836.2003.00293.x
31 https://doi.org/10.1056/nejm200006293422604
32 https://doi.org/10.1093/aje/kwr268
33 https://doi.org/10.1111/j.1538-7836.2008.02928.x
34 https://doi.org/10.1111/j.1538-7836.2008.03044.x
35 https://doi.org/10.1136/oemed-2012-101211
36 https://doi.org/10.1136/thoraxjnl-2012-202592
37 https://doi.org/10.1182/blood-2010-08-304758
38 https://doi.org/10.1200/jco.2009.22.4584
39 https://doi.org/10.2741/1891
40 schema:datePublished 2014-09
41 schema:datePublishedReg 2014-09-01
42 schema:description PURPOSE: A few recent epidemiological observations suggest that anticoagulant medications may protect against prostate cancer development. Most studies have been small or subjected to methodological issues, including potential confounding. We provide here new evidence on this association in the context of a population-based case-control study of prostate cancer conducted in Montreal, Canada. METHODS: Cases were 1,588 men with incident prostate cancer, aged ≤75 years, diagnosed across French hospitals in the Montreal area between 2005 and 2009. Concurrently, 1,618 population controls from the same residential area and age distribution (±5 years) were randomly selected from the electoral list of French-speaking men. In-person interviews elicited information on socio-demographic, lifestyle and environmental factors, along with a detailed medical history. Unconditional logistic regression was used to assess the association between lifetime use of anticoagulants and prostate cancer risk. RESULTS: 102 subjects (2.6 % of cases and 3.7 % of controls) reported a history of oral anticoagulant therapy. After controlling for age, ancestry, education, family history of prostate cancer, prostate cancer screening frequency, diabetes, body mass index and statin use, ever use of oral anticoagulants showed a weak inverse, non-statistically significant association with prostate cancer (odds ratio 0.76, 95% confidence interval 0.50-1.16). Similar results were observed in analyses considering duration of use or indication for use, restricted to subjects recently screened or stratified by cancer aggressiveness. CONCLUSIONS: Our findings provide weak support for a protective effect of oral anticoagulant therapy against prostate cancer. Further confirmation is required, especially in light of potential bleeding complications associated with anticoagulants.
43 schema:genre research_article
44 schema:inLanguage en
45 schema:isAccessibleForFree false
46 schema:isPartOf N83529d8f75314a1db74c9f87f9771d09
47 Na8a078bc1cb743c1ad137b251a977953
48 sg:journal.1100917
49 schema:name Use of oral anticoagulants and risk of prostate cancer: a population-based case–control study in Montreal, Canada
50 schema:pagination 1159-1166
51 schema:productId N25110ed93e134fd7b9d16150de8f0a2f
52 N26b6f988c34b4d57ae60bd95cf83adb3
53 N33d7a683f5ac415f91ccb00d4bf80ad9
54 N346a6d7e5c164b6fa14b1979730b45e1
55 Nbd2672ea5dba431485e5788ca731042e
56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000302615
57 https://doi.org/10.1007/s10552-014-0417-z
58 schema:sdDatePublished 2019-04-10T17:24
59 schema:sdLicense https://scigraph.springernature.com/explorer/license/
60 schema:sdPublisher Nd25fc8f0500f413c963732e011b2ea25
61 schema:url http://link.springer.com/10.1007/s10552-014-0417-z
62 sgo:license sg:explorer/license/
63 sgo:sdDataset articles
64 rdf:type schema:ScholarlyArticle
65 N0304d1260c934a108f51c1c75163f17b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Male
67 rdf:type schema:DefinedTerm
68 N0b85c62681f0444ea71a74f981bb9e9f rdf:first sg:person.01106133736.60
69 rdf:rest Na812ef03a7e94ba7a19fc0257a526350
70 N0f833ce8b83540d2acd70b39a00e78bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Aged
72 rdf:type schema:DefinedTerm
73 N11c13a4c4c02455fbb1821ed9feb57d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Logistic Models
75 rdf:type schema:DefinedTerm
76 N1c80dfab14c6406cbef6848273ed5bb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Odds Ratio
78 rdf:type schema:DefinedTerm
79 N1fa2eb743ea249718c01964c04f00a81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Case-Control Studies
81 rdf:type schema:DefinedTerm
82 N25110ed93e134fd7b9d16150de8f0a2f schema:name doi
83 schema:value 10.1007/s10552-014-0417-z
84 rdf:type schema:PropertyValue
85 N26b6f988c34b4d57ae60bd95cf83adb3 schema:name nlm_unique_id
86 schema:value 9100846
87 rdf:type schema:PropertyValue
88 N3115b1bd7ca0430ba5221581a52eae64 rdf:first sg:person.01202354504.36
89 rdf:rest N0b85c62681f0444ea71a74f981bb9e9f
90 N33d7a683f5ac415f91ccb00d4bf80ad9 schema:name readcube_id
91 schema:value 01702535e5df8c5ed3c4c3c49108bc6fada21e0cbc90ab554cfa625cccfcefb1
92 rdf:type schema:PropertyValue
93 N3426d016172c4070922a1a10418ace10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Middle Aged
95 rdf:type schema:DefinedTerm
96 N346a6d7e5c164b6fa14b1979730b45e1 schema:name dimensions_id
97 schema:value pub.1000302615
98 rdf:type schema:PropertyValue
99 N3ef97a0f2e41443d97d81cb7d5cfcdbd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Anticoagulants
101 rdf:type schema:DefinedTerm
102 N50e892c5f9694af49a209f0645359663 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Ethnic Groups
104 rdf:type schema:DefinedTerm
105 N61329f7f3fc649f39eaa92676518dda2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Interviews as Topic
107 rdf:type schema:DefinedTerm
108 N652cc32bfa3c43f0ab7c8947ab111ca6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Administration, Oral
110 rdf:type schema:DefinedTerm
111 N67545b034eef475d877b10d1c81bd1db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Prostatic Neoplasms
113 rdf:type schema:DefinedTerm
114 N6dd5c8631ea74827836e5cfc43771332 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Age Factors
116 rdf:type schema:DefinedTerm
117 N83529d8f75314a1db74c9f87f9771d09 schema:volumeNumber 25
118 rdf:type schema:PublicationVolume
119 Na812ef03a7e94ba7a19fc0257a526350 rdf:first sg:person.01260315672.25
120 rdf:rest rdf:nil
121 Na8a078bc1cb743c1ad137b251a977953 schema:issueNumber 9
122 rdf:type schema:PublicationIssue
123 Nb9ddcf6a48594073953d5b74fc03a474 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Quebec
125 rdf:type schema:DefinedTerm
126 Nbd2672ea5dba431485e5788ca731042e schema:name pubmed_id
127 schema:value 24946744
128 rdf:type schema:PropertyValue
129 Nd25fc8f0500f413c963732e011b2ea25 schema:name Springer Nature - SN SciGraph project
130 rdf:type schema:Organization
131 Ne1ff597e47d040a1bc8b9248c0d5f0da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Humans
133 rdf:type schema:DefinedTerm
134 Nf3a57c81b24142259874a914a4c95617 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Risk Factors
136 rdf:type schema:DefinedTerm
137 Nf509e1d24be94675b3a48d111f72a6fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Body Mass Index
139 rdf:type schema:DefinedTerm
140 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
141 schema:name Medical and Health Sciences
142 rdf:type schema:DefinedTerm
143 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
144 schema:name Public Health and Health Services
145 rdf:type schema:DefinedTerm
146 sg:journal.1100917 schema:issn 0957-5243
147 1573-7225
148 schema:name Cancer Causes & Control
149 rdf:type schema:Periodical
150 sg:person.01106133736.60 schema:affiliation https://www.grid.ac/institutes/grid.418084.1
151 schema:familyName Weiss
152 schema:givenName Deborah
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106133736.60
154 rdf:type schema:Person
155 sg:person.01202354504.36 schema:affiliation https://www.grid.ac/institutes/grid.418084.1
156 schema:familyName Blanc-Lapierre
157 schema:givenName Audrey
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202354504.36
159 rdf:type schema:Person
160 sg:person.01260315672.25 schema:affiliation https://www.grid.ac/institutes/grid.410559.c
161 schema:familyName Parent
162 schema:givenName Marie-Élise
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260315672.25
164 rdf:type schema:Person
165 https://app.dimensions.ai/details/publication/pub.1076606316 schema:CreativeWork
166 https://app.dimensions.ai/details/publication/pub.1077469842 schema:CreativeWork
167 https://app.dimensions.ai/details/publication/pub.1081728229 schema:CreativeWork
168 https://doi.org/10.1002/cncr.22892 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030280079
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1002/pds.1943 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009876921
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1016/j.biopha.2003.11.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022119176
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1016/j.jclinepi.2012.04.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002232854
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1016/s0140-6736(97)10018-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037335380
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1016/s0895-4356(97)00040-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045577952
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1016/s1470-2045(07)70046-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005839562
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1046/j.1538-7836.2003.00293.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1002539354
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1056/nejm200006293422604 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007215434
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1093/aje/kwr268 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000858088
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1111/j.1538-7836.2008.02928.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1049082481
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1111/j.1538-7836.2008.03044.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1001482733
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1136/oemed-2012-101211 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025048974
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1136/thoraxjnl-2012-202592 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017817423
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1182/blood-2010-08-304758 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033876215
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1200/jco.2009.22.4584 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033231702
199 rdf:type schema:CreativeWork
200 https://doi.org/10.2741/1891 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070914174
201 rdf:type schema:CreativeWork
202 https://www.grid.ac/institutes/grid.410559.c schema:alternateName Centre Hospitalier de l’Université de Montréal
203 schema:name Department of Social and Preventive Medicine, Université de Montréal, Montréal, QC, Canada
204 Epidemiology and Biostatistics Unit, INRS-Institut Armand-Frappier, Université du Québec, 531 Boul. des Prairies, Building 12, H7V 1B7, Laval, QC, Canada
205 University of Montreal Hospital Research Centre, Montréal, QC, Canada
206 rdf:type schema:Organization
207 https://www.grid.ac/institutes/grid.418084.1 schema:alternateName Institut National de la Recherche Scientifique
208 schema:name Epidemiology and Biostatistics Unit, INRS-Institut Armand-Frappier, Université du Québec, 531 Boul. des Prairies, Building 12, H7V 1B7, Laval, QC, Canada
209 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...